2024 Onco-Nephrology Symposium — On Demand

Specialties

Overview

We’re pleased to present an on-demand option for the 2024 Onco-Nephrology Symposium, originally held live on September 13-14, 2024. This program is designed for the entire healthcare team managing patients with both cancer and kidney disease, offering a comprehensive look at the multidisciplinary nature of onco-nephrology.

Leading experts in plasma cell disorders—including multiple myeloma, amyloidosis, and monoclonal gammopathies—along with distinguished speakers on CAR T cell and other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes, present a comprehensive array of topics at the intersection of cancer and kidney disease. For further information about this program and session topics, view the brochure from the live course.

Objectives

1. Outline a comprehensive assessment and treatment of thrombotic microangiopathy
2. Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
3. Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
4. Recognize renal and non-renal toxicities of modern cancer therapy
5. Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
6. Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
7. Review assessment and management of glomerular disorders in cancer patients
8. Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney